Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 5 | |
Hold | 3 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in INR
The 14 analysts offering 12 month price targets for Mankind Pharma Ltd have a median target of 2,852.50, with a high estimate of 3,300.00 and a low estimate of 2,040.00. The median estimate represents a 11.42% increase from the last price of 2,560.10.
High | 28.9% | 3,300.00 |
Med | 11.4% | 2,852.50 |
Low | -20.3% | 2,040.00 |
Dividends
Div growth (TTM) | -- |
---|
More ▼
Earnings history & estimates in INR
The next earnings announcement is expected on Feb 03, 2025.
Average growth rate | +7.50% |
Average growth rate | +49.00% |
More ▼
Revenue history & estimates in INR
Average growth rate | +3.69% |
Average growth rate | +18.12% |
More ▼